Search Results

There are 31055 results for: content related to: Stabilisation and humanitarian access in a collapsed state: the Somali case

  1. A Serpent without Teeth. The Conservative Transformism of Jean-Baptiste d’Omalius d’Halloy (1783–1875)

    Centaurus

    Volume 49, Issue 2, May 2007, Pages: 114–137, Raf De Bont

    Version of Record online : 15 JUN 2007, DOI: 10.1111/j.1600-0498.2007.00060.x

  2. States of fragility: stabilisation and its implications for humanitarian action

    Disasters

    Volume 34, Issue s3, October 2010, Pages: S275–S296, Sarah Collinson, Samir Elhawary and Robert Muggah

    Version of Record online : 16 SEP 2010, DOI: 10.1111/j.1467-7717.2010.01206.x

  3. Omalizumab in patients with chronic spontaneous urticaria: a systematic review and GRADE assessment

    British Journal of Dermatology

    Volume 173, Issue 2, August 2015, Pages: 404–415, M.C. Urgert, M.T. van den Elzen, A.C. Knulst, Z. Fedorowicz and E.J. van Zuuren

    Version of Record online : 22 JUL 2015, DOI: 10.1111/bjd.13845

  4. Omalizumab (Xolair): Anti-Immunoglobulin E Treatment in Allergic Diseases

    Handbook of Therapeutic Antibodies

    Claus Kroegel, Martin Foerster, Pages: 951–997, 2008

    Published Online : 1 FEB 2008, DOI: 10.1002/9783527619740.ch37

  5. You have free access to this content
    Poster Session TPS

    Allergy

    Volume 72, Issue S103, August 2017, Pages: 383–757,

    Version of Record online : 30 AUG 2017, DOI: 10.1111/all.13252

  6. Anti-IgE in Persistent Severe Allergic Asthma

    Allergy and Allergic Diseases, Volume 1, Second Edition

    Marc Humbert, Stephen T. Holgate, Howard Fox, Jean Bousquet, Pages: 1661–1686, 2009

    Published Online : 10 FEB 2009, DOI: 10.1002/9781444300918.ch81

  7. You have free access to this content
    EAACI IG Biologicals task force paper on the use of biologic agents in allergic disorders

    Allergy

    Volume 70, Issue 7, July 2015, Pages: 727–754, O. Boyman, C. Kaegi, M. Akdis, S. Bavbek, A. Bossios, A. Chatzipetrou, T. Eiwegger, D. Firinu, T. Harr, E. Knol, A. Matucci, O. Palomares, C. Schmidt-Weber, H.-U. Simon, U. C. Steiner, A. Vultaggio, C. A. Akdis and F. Spertini

    Version of Record online : 24 APR 2015, DOI: 10.1111/all.12616

  8. Chronic Urticaria

    Evidence-Based Dermatology, 3

    Karsten Weller, Marcus Maurer, Pages: 210–222, 2014

    Published Online : 6 JUN 2014, DOI: 10.1002/9781118357606.ch29

  9. The clinical response to omalizumab in CSU patients is linked to and predicted by IgE levels and their change

    Allergy

    Accepted manuscript online: 30 OCT 2017, Ragip Ertas, Kemal Ozyurt, Mustafa Atasoy, Tomasz Hawro and Marcus Maurer

    DOI: 10.1111/all.13345

  10. You have free access to this content
    Poster Discussion Session PDS

    Allergy

    Volume 71, Issue S102, August 2016, Pages: 118–272,

    Version of Record online : 19 AUG 2016, DOI: 10.1111/all.12972

  11. You have free access to this content
    Role of immunmodulators in allergen-specific immunotherapy

    Allergy

    Volume 66, Issue 6, June 2011, Pages: 792–797, M. V. Kopp

    Version of Record online : 18 FEB 2011, DOI: 10.1111/j.1398-9995.2011.02553.x

  12. Coronary Artery Anomalies

    Pediatric Cardiac Surgery, Fourth Edition

    Constantine Mavroudis, Ali Dodge-Khatami, Carl L. Backer, Richard Lorber, Pages: 715–743, 2013

    Published Online : 28 FEB 2013, DOI: 10.1002/9781118320754.ch38

  13. You have free access to this content
    Management and treatment of chronic urticaria (CU)

    Journal of the European Academy of Dermatology and Venereology

    Volume 29, Issue S3, June 2015, Pages: 16–32, M. Maurer, M.K. Church, M. Gonçalo, G. Sussman and M. Sánchez-Borges

    Version of Record online : 4 JUN 2015, DOI: 10.1111/jdv.13198

  14. Omalizumab may not inhibit mast cell and basophil activation in vitro

    Journal of the European Academy of Dermatology and Venereology

    Volume 29, Issue 9, September 2015, Pages: 1832–1836, J. Gericke, T. Ohanyan, M.K. Church, M. Maurer and M. Metz

    Version of Record online : 26 SEP 2014, DOI: 10.1111/jdv.12693

  15. Poster Sessions

    Allergy

    Volume 64, Issue s90, June 2009, Pages: 179–538,

    Version of Record online : 18 MAY 2009, DOI: 10.1111/j.1398-9995.2009.02076.x

  16. You have full text access to this OnlineOpen article
    Pharmacokinetics, pharmacodynamics and safety of QGE031 (ligelizumab), a novel high-affinity anti-IgE antibody, in atopic subjects

    Clinical & Experimental Allergy

    Volume 44, Issue 11, November 2014, Pages: 1371–1385, J. P. Arm, I. Bottoli, A. Skerjanec, D. Floch, A. Groenewegen, S. Maahs, C. E. Owen, I. Jones and P. J. Lowe

    Version of Record online : 21 OCT 2014, DOI: 10.1111/cea.12400

  17. Immunoglobulin E Blockade in the Treatment of Asthma

    Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy

    Volume 27, Issue 10, October 2007, Pages: 1412–1424, Robert Kuhn

    Version of Record online : 6 JAN 2012, DOI: 10.1592/phco.27.10.1412

  18. Intranasal administration of allergen increases specific IgE whereas intranasal Omalizumab does not increase serum IgE levels – a pilot study

    Allergy

    Accepted manuscript online: 30 OCT 2017, Julia Eckl-Dorna, Renate Fröschl, Christian Lupinek, Renata Kiss, Pia Gattinger, Katharina Marth, Raffaela Campana, Katharina Blatt, Peter Valent, Regina Selb, Andrea Mayer, Katharina Gangl, Irene Steiner, Jutta Gamper, Thomas Perkmann, Petra Zieglmayer, Philippe Gevaert, Rudolf Valenta and Verena Niederberger

    DOI: 10.1111/all.13343

  19. You have free access to this content
    Poster Session TPS 34-48

    Allergy

    Volume 71, Issue S102, August 2016, Pages: 528–591,

    Version of Record online : 19 AUG 2016, DOI: 10.1111/all.12978

  20. You have free access to this content
    Poster Session Group III – Green TPS 39

    Allergy

    Volume 70, Issue S101, September 2015, Pages: 527–613,

    Version of Record online : 22 SEP 2015, DOI: 10.1111/all.12721